Corrigendum to "Correlation between immune-related adverse events and efficacy in non-small cell lung cancer treated with nivolumab" [Lung Cancer 115 (2018) 71-74]

Lung Cancer. 2018 Dec:126:230-231. doi: 10.1016/j.lungcan.2018.11.007. Epub 2018 Nov 18.

Affiliations

¹ Third Department of Internal Medicine, Wakayama Medical University, Japan.
² Third Department of Internal Medicine, Wakayama Medical University, Japan. Electronic address: h-akamat@wakayama-med.ac.jp.

PMID: 30459086
DOI: 10.1016/j.lungcan.2018.11.007

No abstract available

Publication types

Published Erratum